Neurocrine Likely To Seek Women’s Health Partner For Endometriosis Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Neurocrine expects to carry development of its gonadotrophin-releasing hormone receptor antagonist through Phase IIb before partnering.